0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncology (Anti-cancer Drugs) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-19J7533
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
China Oncology Anti cancer Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Oncology (Anti-cancer Drugs) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19J7533
Report
September 2024
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology (Anti-cancer Drugs) - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology (Anti-cancer Drugs) - Market

Oncology (Anti-cancer Drugs) - Market

The global market for Oncology (Anti-cancer Drugs) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology (Anti-cancer Drugs), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oncology (Anti-cancer Drugs) by region & country, by Type, and by Application.
The Oncology (Anti-cancer Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology (Anti-cancer Drugs).
Market Segmentation

Scope of Oncology (Anti-cancer Drugs) - Market Report

Report Metric Details
Report Name Oncology (Anti-cancer Drugs) - Market
CAGR 5%
Segment by Type:
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Others
Segment by Application
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly, Pfizer, Merck, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Oncology (Anti-cancer Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Oncology (Anti-cancer Drugs) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Oncology (Anti-cancer Drugs) - Market report?

Ans: The main players in the Oncology (Anti-cancer Drugs) - Market are Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly, Pfizer, Merck, Sanofi

What are the Application segmentation covered in the Oncology (Anti-cancer Drugs) - Market report?

Ans: The Applications covered in the Oncology (Anti-cancer Drugs) - Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

What are the Type segmentation covered in the Oncology (Anti-cancer Drugs) - Market report?

Ans: The Types covered in the Oncology (Anti-cancer Drugs) - Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Others

1 Market Overview
1.1 Oncology (Anti-cancer Drugs) Product Introduction
1.2 Global Oncology (Anti-cancer Drugs) Market Size Forecast
1.2.1 Global Oncology (Anti-cancer Drugs) Sales Value (2019-2030)
1.2.2 Global Oncology (Anti-cancer Drugs) Sales Volume (2019-2030)
1.2.3 Global Oncology (Anti-cancer Drugs) Sales Price (2019-2030)
1.3 Oncology (Anti-cancer Drugs) Market Trends & Drivers
1.3.1 Oncology (Anti-cancer Drugs) Industry Trends
1.3.2 Oncology (Anti-cancer Drugs) Market Drivers & Opportunity
1.3.3 Oncology (Anti-cancer Drugs) Market Challenges
1.3.4 Oncology (Anti-cancer Drugs) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology (Anti-cancer Drugs) Players Revenue Ranking (2023)
2.2 Global Oncology (Anti-cancer Drugs) Revenue by Company (2019-2024)
2.3 Global Oncology (Anti-cancer Drugs) Players Sales Volume Ranking (2023)
2.4 Global Oncology (Anti-cancer Drugs) Sales Volume by Company Players (2019-2024)
2.5 Global Oncology (Anti-cancer Drugs) Average Price by Company (2019-2024)
2.6 Key Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oncology (Anti-cancer Drugs) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oncology (Anti-cancer Drugs)
2.9 Oncology (Anti-cancer Drugs) Market Competitive Analysis
2.9.1 Oncology (Anti-cancer Drugs) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oncology (Anti-cancer Drugs) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Cancer
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Prostate Cancer
3.1.5 Others
3.2 Global Oncology (Anti-cancer Drugs) Sales Value by Type
3.2.1 Global Oncology (Anti-cancer Drugs) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology (Anti-cancer Drugs) Sales Value, by Type (2019-2030)
3.2.3 Global Oncology (Anti-cancer Drugs) Sales Value, by Type (%) (2019-2030)
3.3 Global Oncology (Anti-cancer Drugs) Sales Volume by Type
3.3.1 Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oncology (Anti-cancer Drugs) Sales Volume, by Type (2019-2030)
3.3.3 Global Oncology (Anti-cancer Drugs) Sales Volume, by Type (%) (2019-2030)
3.4 Global Oncology (Anti-cancer Drugs) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chemotherapy
4.1.2 Targeted Therapy
4.1.3 Immunotherapy (Biologic Therapy)
4.1.4 Hormonal Therapy
4.1.5 Others
4.2 Global Oncology (Anti-cancer Drugs) Sales Value by Application
4.2.1 Global Oncology (Anti-cancer Drugs) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology (Anti-cancer Drugs) Sales Value, by Application (2019-2030)
4.2.3 Global Oncology (Anti-cancer Drugs) Sales Value, by Application (%) (2019-2030)
4.3 Global Oncology (Anti-cancer Drugs) Sales Volume by Application
4.3.1 Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oncology (Anti-cancer Drugs) Sales Volume, by Application (2019-2030)
4.3.3 Global Oncology (Anti-cancer Drugs) Sales Volume, by Application (%) (2019-2030)
4.4 Global Oncology (Anti-cancer Drugs) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oncology (Anti-cancer Drugs) Sales Value by Region
5.1.1 Global Oncology (Anti-cancer Drugs) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology (Anti-cancer Drugs) Sales Value by Region (2019-2024)
5.1.3 Global Oncology (Anti-cancer Drugs) Sales Value by Region (2025-2030)
5.1.4 Global Oncology (Anti-cancer Drugs) Sales Value by Region (%), (2019-2030)
5.2 Global Oncology (Anti-cancer Drugs) Sales Volume by Region
5.2.1 Global Oncology (Anti-cancer Drugs) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2019-2024)
5.2.3 Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2025-2030)
5.2.4 Global Oncology (Anti-cancer Drugs) Sales Volume by Region (%), (2019-2030)
5.3 Global Oncology (Anti-cancer Drugs) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
5.4.2 North America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
5.5.2 Europe Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
5.6.2 Asia Pacific Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
5.7.2 South America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
5.8.2 Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value
6.2.1 Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.3.2 United States Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.4.2 Europe Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.5.2 China Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.6.2 Japan Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.7.2 South Korea Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology (Anti-cancer Drugs) Sales Value, 2019-2030
6.9.2 India Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology (Anti-cancer Drugs) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Oncology (Anti-cancer Drugs) Product Offerings
7.1.5 Roche Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Introduction and Business Overview
7.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis Oncology (Anti-cancer Drugs) Product Offerings
7.2.5 Novartis Recent Development
7.3 Celgene
7.3.1 Celgene Company Information
7.3.2 Celgene Introduction and Business Overview
7.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Celgene Oncology (Anti-cancer Drugs) Product Offerings
7.3.5 Celgene Recent Development
7.4 Amgen
7.4.1 Amgen Company Information
7.4.2 Amgen Introduction and Business Overview
7.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Amgen Oncology (Anti-cancer Drugs) Product Offerings
7.4.5 Amgen Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Introduction and Business Overview
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Offerings
7.5.5 Johnson & Johnson Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Information
7.6.2 GlaxoSmithKline Introduction and Business Overview
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Offerings
7.6.5 GlaxoSmithKline Recent Development
7.7 Eli lilly
7.7.1 Eli lilly Company Information
7.7.2 Eli lilly Introduction and Business Overview
7.7.3 Eli lilly Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Eli lilly Oncology (Anti-cancer Drugs) Product Offerings
7.7.5 Eli lilly Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Oncology (Anti-cancer Drugs) Product Offerings
7.8.5 Pfizer Recent Development
7.9 Merck
7.9.1 Merck Company Information
7.9.2 Merck Introduction and Business Overview
7.9.3 Merck Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck Oncology (Anti-cancer Drugs) Product Offerings
7.9.5 Merck Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Information
7.10.2 Sanofi Introduction and Business Overview
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sanofi Oncology (Anti-cancer Drugs) Product Offerings
7.10.5 Sanofi Recent Development
8 Industry Chain Analysis
8.1 Oncology (Anti-cancer Drugs) Industrial Chain
8.2 Oncology (Anti-cancer Drugs) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology (Anti-cancer Drugs) Sales Model
8.5.2 Sales Channel
8.5.3 Oncology (Anti-cancer Drugs) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oncology (Anti-cancer Drugs) Market Trends
    Table 2. Oncology (Anti-cancer Drugs) Market Drivers & Opportunity
    Table 3. Oncology (Anti-cancer Drugs) Market Challenges
    Table 4. Oncology (Anti-cancer Drugs) Market Restraints
    Table 5. Global Oncology (Anti-cancer Drugs) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Company (2019-2024)
    Table 7. Global Oncology (Anti-cancer Drugs) Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oncology (Anti-cancer Drugs) Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oncology (Anti-cancer Drugs) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oncology (Anti-cancer Drugs)
    Table 13. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oncology (Anti-cancer Drugs) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oncology (Anti-cancer Drugs) Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oncology (Anti-cancer Drugs) Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Oncology (Anti-cancer Drugs) Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Oncology (Anti-cancer Drugs) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oncology (Anti-cancer Drugs) Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oncology (Anti-cancer Drugs) Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Oncology (Anti-cancer Drugs) Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Oncology (Anti-cancer Drugs) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oncology (Anti-cancer Drugs) Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Oncology (Anti-cancer Drugs) Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume, (2025-2030) & (K MT)
    Table 57. Roche Company Information
    Table 58. Roche Introduction and Business Overview
    Table 59. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Roche Oncology (Anti-cancer Drugs) Product Offerings
    Table 61. Roche Recent Development
    Table 62. Novartis Company Information
    Table 63. Novartis Introduction and Business Overview
    Table 64. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Novartis Oncology (Anti-cancer Drugs) Product Offerings
    Table 66. Novartis Recent Development
    Table 67. Celgene Company Information
    Table 68. Celgene Introduction and Business Overview
    Table 69. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Celgene Oncology (Anti-cancer Drugs) Product Offerings
    Table 71. Celgene Recent Development
    Table 72. Amgen Company Information
    Table 73. Amgen Introduction and Business Overview
    Table 74. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Amgen Oncology (Anti-cancer Drugs) Product Offerings
    Table 76. Amgen Recent Development
    Table 77. Johnson & Johnson Company Information
    Table 78. Johnson & Johnson Introduction and Business Overview
    Table 79. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Offerings
    Table 81. Johnson & Johnson Recent Development
    Table 82. GlaxoSmithKline Company Information
    Table 83. GlaxoSmithKline Introduction and Business Overview
    Table 84. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Offerings
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Eli lilly Company Information
    Table 88. Eli lilly Introduction and Business Overview
    Table 89. Eli lilly Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Eli lilly Oncology (Anti-cancer Drugs) Product Offerings
    Table 91. Eli lilly Recent Development
    Table 92. Pfizer Company Information
    Table 93. Pfizer Introduction and Business Overview
    Table 94. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Pfizer Oncology (Anti-cancer Drugs) Product Offerings
    Table 96. Pfizer Recent Development
    Table 97. Merck Company Information
    Table 98. Merck Introduction and Business Overview
    Table 99. Merck Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Merck Oncology (Anti-cancer Drugs) Product Offerings
    Table 101. Merck Recent Development
    Table 102. Sanofi Company Information
    Table 103. Sanofi Introduction and Business Overview
    Table 104. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Sanofi Oncology (Anti-cancer Drugs) Product Offerings
    Table 106. Sanofi Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Oncology (Anti-cancer Drugs) Downstream Customers
    Table 110. Oncology (Anti-cancer Drugs) Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology (Anti-cancer Drugs) Product Picture
    Figure 2. Global Oncology (Anti-cancer Drugs) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oncology (Anti-cancer Drugs) Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Oncology (Anti-cancer Drugs) Sales Price (2019-2030) & (USD/MT)
    Figure 6. Oncology (Anti-cancer Drugs) Report Years Considered
    Figure 7. Global Oncology (Anti-cancer Drugs) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oncology (Anti-cancer Drugs) Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Revenue in 2023
    Figure 10. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Blood Cancer Picture
    Figure 12. Breast Cancer Picture
    Figure 13. Gastrointestinal Cancer Picture
    Figure 14. Prostate Cancer Picture
    Figure 15. Others Picture
    Figure 16. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Oncology (Anti-cancer Drugs) Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 19. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Oncology (Anti-cancer Drugs) Price by Type (2019-2030) & (USD/MT)
    Figure 21. Product Picture of Chemotherapy
    Figure 22. Product Picture of Targeted Therapy
    Figure 23. Product Picture of Immunotherapy (Biologic Therapy)
    Figure 24. Product Picture of Hormonal Therapy
    Figure 25. Product Picture of Others
    Figure 26. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Oncology (Anti-cancer Drugs) Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 29. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Oncology (Anti-cancer Drugs) Price by Application (2019-2030) & (USD/MT)
    Figure 31. North America Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume (%), (2019-2030)
    Figure 43. United States Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
    Figure 64. Oncology (Anti-cancer Drugs) Industrial Chain
    Figure 65. Oncology (Anti-cancer Drugs) Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS